
Tempramed receives Chinese patent for Vivi Box
Tempramed receives Chinese patent for Vivi Box

Tempramed receives Chinese patent for Vivi Box
Sernova closes $2.1-million private placement
Spectral, Vantive release Tigris results in Lancet
Bionxt talks up global patent coverage for ODF
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
UberDoc Health Technologies Corp. Announces Listing on the Frankfurt Stock Exchange
Rocket Doctor Expands California Coverage with New In-Network Agreement with a National Insurer, Adding Over 2 Million Members
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Quantum Biopharma highlights unbuzzd trial results
Aptose Bio gets Glass, Lewis support for takeover
Perimeter Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 31st; Provides Corporate Update